Fennec Pharmaceuticals (NASDAQ: FENC) reported Q4 EPS of ($0.06), $0.07 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.92 million versus the consensus estimate of $7.88 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.